rosuvastatinatorvastatinPWHdiabetes mellitusDMHIV
…essment for insulin resistance (HOMA-IR) among PWH treated with rosuvastatin vs. atorvastatin. The secondary objectives were to evaluate bas…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 70 of 2459HIVsemaglutidePWHAntiretroviral therapyEQ-5DART
…th metabolic complications prescribed semaglutide at the Modena HIV Metabolic Clinic, Italy, from January 2020 to September 2025. B…
SelexipagPulmonary arterial hypertension (PAH)Systemic sclerosis (SSc)SSc-PAH
…arting Selexipag within 2 years from PAH diagnosis. Reasons for Selexipag discontinuation included 5 (11.4%) adverse drug reactions (ADR)…
rifaximinmetronidazoleJewish General Hospitaltetracyclineamoxicillin/clavulanatesystemic sclerosis (SSc)VancomycinSScsulfonamideCentre hospitalier de l’Université de Sherbrooke+1 more
…clavulanate (33%), metronidazole (31%), tetracycline (21%), and rifaximin (10%), with response rates ranging from 47% to 65%. Vancomycin …
calcium channel blockers5-phosphodiesterase inhibitorsprostacyclin analogsSScsystemic sclerosissRPendothelin-receptor antagonistspRP
…esterase inhibitors were excluded. Other vasoactive treatments (calcium channel blockers) were stopped two days before the experiments. Forty-two female…
morpheahydroxychloroquineSjögren’s diseasemethotrexateHashimoto thyroiditisCrohn’s diseaseerythema nodosumtype 1 diabetescyclosporineosteoporosis+1 more
…une comorbidity underscores the shared autoimmune background of morphea. Malignancies presented in 11.1% of patients highlighting the n…
AmlitelimabSScsystemic sclerosisCONQUEST
…einase inhibitors (MMPs) were identified of potential interest. Amlitelimab (anti-OX40L monoclonal antibody) is currently being explored in…
rituximabSScsystemic sclerosisMMF-RTXmycophenolate mofetilMMF
…nation treatment with mycophenolate and rituximab (MMF-RTX) vs. rituximab monotherapy (RTX) in a single-center cohort of patients affecte…
systemic sclerosisSjogren’s diseaseSScSjögren’s disease (SD)SD
…racteristcs of patients with primary Sjogren’s disease (SD) and systemic sclerosis (SSc)Abstract P.390 Table 2Association between OMERACT salivary…
rheumatoid arthritissystemic lupus erythematosuspsoriasisLL37systemic sclerosis
…ith increased local inflammation in various conditions, such as rheumatoid arthritis, psoriasis, and systemic lupus erythematosus. Its role in syste…
ocrelizumabNatalizumabFingolimodAlemtuzumabmultiple sclerosis
…pse risk (1.35, 1.16 to 1.57) and RAW (1.77, 1.07 to 2.94) than ocrelizumab. Alemtuzumab was associated with higher ARR (0.18 vs 0.12, p<0.…
Sepsis-3presepsinsepsisseptic shockprocalcitonin
…ck. Presepsin levels were significantly higher in patients with Sepsis-3 than in patients without sepsis at ED admission and decreased o…